Literature DB >> 30963283

Association between BMI changes and mortality risk in children with end-stage renal disease.

Matthew J Roberts1, Mark M Mitsnefes2, Charles E McCulloch3, Larry A Greenbaum4, Barbara A Grimes3, Elaine Ku5,6.   

Abstract

BACKGROUND: Few studies have examined how changes in BMI [body mass index] over time associate with risk of adverse outcomes in children receiving renal replacement therapy [RRT]. The objective of this study was to examine the association between annualized changes in BMI and the risk of death in children treated with RRT.
METHODS: We performed a retrospective cohort study of 1182 pediatric dialysis and transplant patients in the Pediatric Growth and Development Special Study of the United States Renal Data System. Quintiles of annualized change in BMI z-score (with cutoffs of - 0.50, - 0.13, 0.09, 0.57) were used as the primary predictor, with the middle quintile (- 0.13 to 0.09) serving as the reference category. Cox models were used to examine the association between exposure and death, with time of analysis starting from the second BMI measurement.
RESULTS: Median follow-up time to death or censoring was 6 years. Median age was 14.6 years, and 61% of children had a functional graft at cohort entry. There was a U-shaped association between BMI change and mortality risk: a large decline in annualized BMI z-score change (> - 0.50) was associated with an increased risk of death (adjusted hazard ratio [aHR] 1.54 (95% CI 1.17-2.03), p = 0.002). A large increase in annualized BMI z-score change (> 0.57) was also associated with an increased risk of death (aHR 1.44 (95% CI 1.07-1.92), p = 0.02). No interaction was noted between annualized BMI change and initial treatment modality (dialysis or transplant, p = 0.15).
CONCLUSIONS: Maintenance of a stable BMI in pediatric patients receiving RRT may be associated with improved survival.

Entities:  

Keywords:  Body mass index; ESRD; Malnutrition; Obesity; Pediatrics

Mesh:

Year:  2019        PMID: 30963283     DOI: 10.1007/s00467-019-04249-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  25 in total

1.  Childhood obesity, other cardiovascular risk factors, and premature death.

Authors:  Paul W Franks; Robert L Hanson; William C Knowler; Maurice L Sievers; Peter H Bennett; Helen C Looker
Journal:  N Engl J Med       Date:  2010-02-11       Impact factor: 91.245

Review 2.  Trends in the use of glucocorticoids in renal transplantation.

Authors:  D E Hricik; W Y Almawi; T B Strom
Journal:  Transplantation       Date:  1994-04-15       Impact factor: 4.939

3.  C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Authors:  Finnian R Mc Causland; Brian Claggett; Emmanuel A Burdmann; Kai-Uwe Eckardt; Reshma Kewalramani; Andrew S Levey; John J V McMurray; Patrick Parfrey; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert D Toto; Marc A Pfeffer
Journal:  Am J Kidney Dis       Date:  2016-09-16       Impact factor: 8.860

4.  Association of Body Mass Index with Patient-Centered Outcomes in Children with ESRD.

Authors:  Elaine Ku; David V Glidden; Chi-yuan Hsu; Anthony A Portale; Barbara Grimes; Kirsten L Johansen
Journal:  J Am Soc Nephrol       Date:  2015-06-08       Impact factor: 10.121

5.  Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients.

Authors:  Carmine Zoccali; Francesca Mallamaci; Francesco Antonio Benedetto; Giovanni Tripepi; Saverio Parlongo; Alessandro Cataliotti; Sebastiano Cutrupi; Giuseppe Giacone; Ignazio Bellanuova; Emilio Cottini; Lorenzo Salvatore Malatino
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

6.  Anthropometric measures and risk of death in children with end-stage renal disease.

Authors:  C S Wong; D S Gipson; D L Gillen; S Emerson; T Koepsell; D J Sherrard; S L Watkins; C Stehman-Breen
Journal:  Am J Kidney Dis       Date:  2000-10       Impact factor: 8.860

7.  2000 CDC Growth Charts for the United States: methods and development.

Authors:  Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson
Journal:  Vital Health Stat 11       Date:  2002-05

8.  Chronic kidney disease: Obesity in children with end-stage renal disease.

Authors:  Rafael T Krmar; Peter Bárány
Journal:  Nat Rev Nephrol       Date:  2013-10-22       Impact factor: 28.314

9.  Chronic kidney disease and the risk of end-stage renal disease versus death.

Authors:  Lorien S Dalrymple; Ronit Katz; Bryan Kestenbaum; Michael G Shlipak; Mark J Sarnak; Catherine Stehman-Breen; Stephen Seliger; David Siscovick; Anne B Newman; Linda Fried
Journal:  J Gen Intern Med       Date:  2010-09-19       Impact factor: 5.128

10.  Pretransplant malnutrition, inflammation, and atherosclerosis affect cardiovascular outcomes after kidney transplantation.

Authors:  Jin Ho Hwang; Jiwon Ryu; Jung Nam An; Clara Tammy Kim; Hyosang Kim; Jaeseok Yang; Jongwon Ha; Dong Wan Chae; Curie Ahn; In Mok Jung; Yun Kyu Oh; Chun Soo Lim; Duck-Jong Han; Su-Kil Park; Yon Su Kim; Young Hoon Kim; Jung Pyo Lee
Journal:  BMC Nephrol       Date:  2015-07-21       Impact factor: 2.388

View more
  2 in total

Review 1.  Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies.

Authors:  Ryoko Harada; Yuko Hamasaki; Yusuke Okuda; Riku Hamada; Kenji Ishikura
Journal:  Pediatr Nephrol       Date:  2021-06-06       Impact factor: 3.651

Review 2.  Assessment and management of obesity and metabolic syndrome in children with CKD stages 2-5 on dialysis and after kidney transplantation-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.

Authors:  Stella Stabouli; Nonnie Polderman; Christina L Nelms; Fabio Paglialonga; Michiel J S Oosterveld; Larry A Greenbaum; Bradley A Warady; Caroline Anderson; Dieter Haffner; An Desloovere; Leila Qizalbash; José Renken-Terhaerdt; Jetta Tuokkola; Johan Vande Walle; Vanessa Shaw; Mark Mitsnefes; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2021-08-10       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.